EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Enterprise Value (2010 - 2026)

EyePoint (EYPT) posted Enterprise Value of -$222.5 million for Q1 2026, up 27.29% sequentially from -$306.1 million in Q4 2025, and up 30.06% YoY from -$171.1 million in Q1 2025.

Analysis

EyePoint (EYPT) Enterprise Value (2010 - 2026) Analysis & Trends

EyePoint has reported Enterprise Value for 17 years, with the latest figure at -$222.5 million in Q1 2026.

  • Quarterly Enterprise Value rose 30.06% year-over-year to -$222.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$222.5 million (up 30.06% YoY) and the FY2025 annual result came in at -$306.1 million, up 17.48% from the prior year.
  • Enterprise Value rose to -$222.5 million in Q1 2026 per EYPT's latest filing, from -$306.1 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$122.5 million in Q1 2023 and troughed at -$370.9 million in Q4 2024.
  • A 5-year average of -$229.8 million and a median of -$222.5 million in 2026 frame the typical range for Enterprise Value.
  • The sharpest annual moves came in 2023 and 2024: Enterprise Value soared 35.81% in 2023, then sank 144.44% in 2024.
  • Over 5 years, Enterprise Value stood at -$144.6 million in 2022, then tumbled by 129.0% to -$331.0 million in 2023, then decreased by 12.04% to -$370.9 million in 2024, then advanced by 17.48% to -$306.1 million in 2025, then grew by 27.29% to -$222.5 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods registered -$222.5 million, -$306.1 million, and -$204.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.03 Bn
Mar 31, 2026 853.16 Mn
Dec 31, 2025 1.21 Bn
Sep 30, 2025 786.65 Mn
Jun 30, 2025 392.52 Mn
Mar 31, 2025 54.76 Mn
Dec 31, 2024 48.51 Mn
Sep 30, 2024 173.87 Mn
Jun 30, 2024 173.55 Mn
Mar 31, 2024 731.79 Mn
Dec 31, 2023 568.02 Mn
Sep 30, 2023 146.09 Mn
Jun 30, 2023 155.93 Mn
Mar 31, 2023 -21.64 Mn
Dec 31, 2022 -25.27 Mn
Sep 30, 2022 112.25 Mn
Jun 30, 2022 96.83 Mn
Mar 31, 2022 222.89 Mn
Dec 31, 2021 203.41 Mn
Sep 30, 2021 180.09 Mn